Key facts
- This page summarizes Brady Stewart's Form 4 filing for Evolus, Inc. (EOLS).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 11 Mar 2025, 18:53.
Brady Stewart - 07 Mar 2025 Form 4 Insider Report for Evolus, Inc. (EOLS)
- Reporting relationship
- Director
- Issuer ticker
- EOLS
- Reported as of
- 07 Mar 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 11 Mar 2025, 18:53:56 UTC
- Prior SEC filing
- 09 Feb 2024
- Next SEC filing
- 18 Aug 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jeffrey J. Plumer, as attorney-in-fact for Brady Stewart
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Brady Stewart filed Form 4 for Evolus, Inc. (EOLS) on 11 Mar 2025.
Change
- Previous filing in this sequence was filed on 09 Feb 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EOLS
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +7,364
- Change %
- +14%
- Price
- $0.000000
- Shares after
- 58,629
- Date
- 07 Mar 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
EOLS
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +11,146
- Change %
- Price
- $0.000000
- Shares after
- 11,146
- Date
- 07 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 11,146
- Exercise price
- $13.58
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of March 7, 2025, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer.
Footnote F2
The shares subject to the option will vest over a period of twelve months, with 1/12th of the shares subject to the option vesting monthly on the anniversary of March 7, 2025, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.